Viatris Acquires Pacira Biosciences for $1.65 Billion; Stock Soars
FROM THE WIRE · FINANCE.YAHOO.COM
Viatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing. Continue Reading
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishViatris announces $1.65 billion acquisition of biotech Pacira, sending stock sharply higher.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Viatris announced Thursday the acquisition of Pacira Biosciences for $1.65 billion.
- 02Pacira stock surged significantly following the deal announcement.
- 03The acquisition represents a major consolidation move in the biotech sector.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Pacira BioSciences, Inc.36.39 USDMarket closedtoday +44.40%Positive Viatris Inc.17.44 USDMarket closedtoday -0.29%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets